Wheat is an important staple food and potent
allergen source. Recently, we isolated a
cDNA coding for wheat
alpha-purothionin which is recognized by wheat food allergic patients at risk for severe wheat-induced
allergy. The purpose of the present study was the biochemical, biophysical and
IgE epitope characterization of recombinant
alpha-purothionin. Synthetic genes coding for
alpha-purothionin were expressed in a prokaryotic system using Escherichia coli and in a eukaryotic expression system based on baculovirus-infected Sf9-insect cells.
Recombinant proteins were purified and characterized by SDS-PAGE, mass spectrometry, circular dichroism, chemical cross-linking and size exclusion chromatography. Five overlapping
peptide were synthesized for
epitope mapping.
Alpha-purothionin-specific rabbit
antibodies were raised to perform
IgE-inhibition experiments and to study the resistance to digestion. The
IgE reactivity of the
proteins and
peptides from ten wheat food allergic patients was studied in non-denaturing RAST-based binding assays.
Alpha-purothionin was expressed in the prokaryotic (EcTri a 37) and in the eukaryotic system (BvTri a 37) as a soluble and monomeric
protein. However, circular dichroism analysis revealed that EcTri a 37 was unfolded whereas BvTri a 37 was a folded
protein. Both
proteins showed comparable
IgE-reactivity and the
epitope mapping revealed the presence of sequential
IgE epitopes in the N-terminal basic
thionin domain (peptide1:KSCCRSTLGRNCYNLCRARGAQKLCAGVCR) and in the C-terminal acidic extension domain (peptide3:KGFPKLALESNSDEPDTIEYCNLGCRSSVC, peptide4:CNLGCRSSVCDYMVNAAADDEEMKLYVEN). Natural Tri a 37 was digested under gastric conditions but resistant to duodenal digestion. Immunization with EcTri a 37 induced
IgG antibodies which recognized similar
epitopes as
IgE antibodies from allergic patients and inhibited allergic patients'
IgE binding. Reactivity to Tri a 37 does not require a folded
protein and the presence of sequential
IgE epitopes indicates that sensitization to
alpha-purothionin occurs via the gut. Both
allergens can be used for in-vitro diagnosis of wheat
food allergy. The induction of blocking
IgG antibodies suggests the usefulness for
immunotherapy.